Solène Ronsin1, Gianluca Deiana1, Ana Filipa Geraldo1, Françoise Durand-Dubief1, Laure Thomas-Maisonneuve1, Maïté Formaglio1, Virginie Desestret1, David Meyronet1, Norbert Nighoghossian1, Yves Berthezène1, Jérôme Honnorat2, François Ducray1. 1. From the Neuro-oncology Department (S.R., L.T.-M., J.H., F.D.), Neuro-radiology Department (G.D., A.F.G., Y.B.), Neurology Department A (F.D.-D.), Neurology Department D (M.F., V.D.), Neuropathology Department (D.M.), and Stroke Unit (N.N.), Hôpital Neurologique, Hospices Civils de Lyon; Université de Lyon-Université Claude Bernard Lyon 1 (S.R., G.D., A.F.G., F.D.-D., L.T.-M., M.F., V.D., D.M., N.N., Y.B., J.H., F.D.), France; Neurology Department and Stroke Unit (G.D.), Ospedale San Francesco, Nuoro, Italy; and Lyon Neuroscience Research Center INSERM U1028/CNRS UMR 5292 (J.H., F.D.), France. 2. From the Neuro-oncology Department (S.R., L.T.-M., J.H., F.D.), Neuro-radiology Department (G.D., A.F.G., Y.B.), Neurology Department A (F.D.-D.), Neurology Department D (M.F., V.D.), Neuropathology Department (D.M.), and Stroke Unit (N.N.), Hôpital Neurologique, Hospices Civils de Lyon; Université de Lyon-Université Claude Bernard Lyon 1 (S.R., G.D., A.F.G., F.D.-D., L.T.-M., M.F., V.D., D.M., N.N., Y.B., J.H., F.D.), France; Neurology Department and Stroke Unit (G.D.), Ospedale San Francesco, Nuoro, Italy; and Lyon Neuroscience Research Center INSERM U1028/CNRS UMR 5292 (J.H., F.D.), France. jérôme.honnorat@chu-lyon.fr.
Abstract
OBJECTIVE: To identify the clinical and radiologic features that should raise suspicion for the pseudotumoral presentation of cerebral amyloid angiopathy-related inflammation (CAA-I). METHODS: We retrospectively reviewed the characteristics of 5 newly diagnosed and 23 previously reported patients in whom the CAA-I imaging findings were initially interpreted as CNS neoplasms. RESULTS: Most cases (85%) occurred in patients >60 years old. The clinical characteristics at presentation included subacute cognitive decline (50%), confusion (32%), focal deficits (32%), seizures (25%), and headaches (21%). Brain MRI demonstrated infiltrative white matter lesions that exhibited a loco-regional mass effect without parenchymal enhancement (93%). In general, these findings were interpreted as low-grade glioma or lymphoma. Eighteen patients (64%) underwent a biopsy, which was nondiagnostic in 4 patients (14%), and 6 patients (21%) underwent a surgical resection. The primary reason for the misinterpretation of the imaging findings was the absence of T2*-weighted gradient recalled echo (T2*-GRE) sequences on initial imaging (89%). When subsequently performed (39%), the T2*-GRE sequences demonstrated multiple characteristic cortical and subcortical microhemorrhages in all cases. Perfusion MRI and magnetic resonance spectroscopy (MRS), which were performed on a subset of patients, indicated markedly reduced relative cerebral blood flow and a normal metabolic ratio. CONCLUSION: The identification of one or several nonenhancing space-occupying lesions, especially in elderly patients presenting with cognitive impairment, should raise suspicion for the pseudotumoral presentation of CAA-I and lead to T2*-GRE sequences. Perfusion MRI and MRS appear to be useful techniques for the differential diagnosis of this entity.
OBJECTIVE: To identify the clinical and radiologic features that should raise suspicion for the pseudotumoral presentation of cerebral amyloid angiopathy-related inflammation (CAA-I). METHODS: We retrospectively reviewed the characteristics of 5 newly diagnosed and 23 previously reported patients in whom the CAA-I imaging findings were initially interpreted as CNS neoplasms. RESULTS: Most cases (85%) occurred in patients >60 years old. The clinical characteristics at presentation included subacute cognitive decline (50%), confusion (32%), focal deficits (32%), seizures (25%), and headaches (21%). Brain MRI demonstrated infiltrative white matter lesions that exhibited a loco-regional mass effect without parenchymal enhancement (93%). In general, these findings were interpreted as low-grade glioma or lymphoma. Eighteen patients (64%) underwent a biopsy, which was nondiagnostic in 4 patients (14%), and 6 patients (21%) underwent a surgical resection. The primary reason for the misinterpretation of the imaging findings was the absence of T2*-weighted gradient recalled echo (T2*-GRE) sequences on initial imaging (89%). When subsequently performed (39%), the T2*-GRE sequences demonstrated multiple characteristic cortical and subcortical microhemorrhages in all cases. Perfusion MRI and magnetic resonance spectroscopy (MRS), which were performed on a subset of patients, indicated markedly reduced relative cerebral blood flow and a normal metabolic ratio. CONCLUSION: The identification of one or several nonenhancing space-occupying lesions, especially in elderly patients presenting with cognitive impairment, should raise suspicion for the pseudotumoral presentation of CAA-I and lead to T2*-GRE sequences. Perfusion MRI and MRS appear to be useful techniques for the differential diagnosis of this entity.
Authors: Kong Khi Chung; Neil E Anderson; David Hutchinson; Beth Synek; P Alan Barber Journal: J Neurol Neurosurg Psychiatry Date: 2010-10-09 Impact factor: 10.154
Authors: Amy L Kotsenas; Jonathan M Morris; John T Wald; Joseph E Parisi; Norbert G Campeau Journal: AJR Am J Roentgenol Date: 2013-01 Impact factor: 3.959
Authors: Fabrizio Piazza; Steven M Greenberg; Mario Savoiardo; Margherita Gardinetti; Luisa Chiapparini; Irina Raicher; Ricardo Nitrini; Hideya Sakaguchi; Monica Brioschi; Giuseppe Billo; Antonio Colombo; Francesca Lanzani; Giuseppe Piscosquito; Maria Rita Carriero; Giorgio Giaccone; Fabrizio Tagliavini; Carlo Ferrarese; Jacopo C DiFrancesco Journal: Ann Neurol Date: 2013-04-26 Impact factor: 10.422
Authors: Carlo Salvarani; Gene G Hunder; Jonathan M Morris; Robert D Brown; Teresa Christianson; Caterina Giannini Journal: Neurology Date: 2013-09-27 Impact factor: 9.910
Authors: James A R Nicoll; David Wilkinson; Clive Holmes; Phil Steart; Hannah Markham; Roy O Weller Journal: Nat Med Date: 2003-03-17 Impact factor: 53.440
Authors: Reisa Sperling; Stephen Salloway; David J Brooks; Donatella Tampieri; Jerome Barakos; Nick C Fox; Murray Raskind; Marwan Sabbagh; Lawrence S Honig; Anton P Porsteinsson; Ivan Lieberburg; H Michael Arrighi; Kristen A Morris; Yuan Lu; Enchi Liu; Keith M Gregg; H Robert Brashear; Gene G Kinney; Ronald Black; Michael Grundman Journal: Lancet Neurol Date: 2012-02-03 Impact factor: 44.182
Authors: Jean-Claude Baron; Karim Farid; Eamon Dolan; Guillaume Turc; Siva T Marrapu; Eoin O'Brien; Franklin I Aigbirhio; Tim D Fryer; David K Menon; Elizabeth A Warburton; Young T Hong Journal: J Cereb Blood Flow Metab Date: 2014-03-12 Impact factor: 6.200
Authors: Elissaios Karageorgiou; Georges Naasan; Samuel J Pleasure; Sanda Alexandrescu; Jeffrey M Gelfand; Gautam Tammewar; Bruce L Miller; Gil D Rabinovici; Lea T Grinberg Journal: Neurol Clin Pract Date: 2017-10
Authors: John M Ringman; Elizabeth Joe; Nasim Sheikh-Bahaei; Carol Miller; Harry V Vinters; Samuel Guzman; Helena C Chui Journal: Alzheimer Dis Assoc Disord Date: 2021 Jul-Sep 01 Impact factor: 2.703
Authors: Claudia Uribe Roca; Fabio Maximiliano Gonzalez; Marta Ines Bala; Miguel Saucedo; Lucrecia Bandeo; Luciana Leon Cejas; Sol Pacha; Pablo Bonardo; Carlos Rugilo; Pablo Dezanzo; Rafael Torino; Gustavo Sevlever; Manuel Fernandez Pardal; Ricardo Reisin Journal: Psychiatry Investig Date: 2021-06-17 Impact factor: 2.505